Cronobacter Species
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Is It Essential to Sequence the Entire 16S Rrna Gene for Bacterial
» INSTRUMENTATION » Is it Essential to Sequence Introduction Bacterial Identification in the biopharmaceutical industry, especially in the Entire 16S rRNA Gene manufacturing facilities, is very important because an occurrence of a problematic microorganism in the final product could be harmful for the end user and detrimental to a company’s finances and reputation. for Bacterial Identification? Environmental Monitoring (EM) programs are the cornerstone of understanding the microbial ecology in a manufacturing facility and have become a regulatory requirement for most manufacturers. The EM program is a biological surveillance system which enables companies to quickly identify organisms which are transient or resident in their facilities before these organisms have an opportunity to contaminate a product. A properly executed EM program provides an early warning of potential contamination problems due to Sunhee Hong, PhD and equipment failure, inadequate cleaning, or deficiencies in staff hygiene Christine E. Farrance, PhD training, for example, so that problems can be corrected to prevent Charles River adulteration of the end product. The Food and Drug Administration (FDA) has published guidelines for the production of sterile drugs by aseptic processing which includes a section on EM programs, and the USP general information chapter “Microbiological Control and Monitoring of Aseptic Processing Environments” also contains detailed information regarding EM programs1. The EM program is only effective if the organisms recovered from the facility are accurately identified, so the information gathered can be used to understand the microbial control through tracking and trending and dictate appropriate remediation activities. There are several different options available for bacterial identification; however, the use of 16S rRNA gene sequences has been considered the most powerful and accurate tool, while conventional phenotypic methods often show major weaknesses2-5. -
CHAPTER 1: General Introduction and Aims 1.1 the Genus Cronobacter: an Introduction
Diversity and virulence of the genus Cronobacter revealed by multilocus sequence typing (MLST) and comparative genomic analysis Susan Manju Joseph A thesis submitted in partial fulfilment of the requirements of Nottingham Trent University for the degree of Doctor of Philosophy July 2013 Experimental work contained in this thesis is original research carried out by the author, unless otherwise stated, in the School of Science and Technology at the Nottingham Trent University. No material contained herein has been submitted for any other degree, or at any other institution. This work is the intellectual property of the author. You may copy up to 5% of this work for private study, or personal, non-commercial research. Any re-use of the information contained within this document should be fully referenced, quoting the author, title, university, degree level and pagination. Queries or requests for any other use, or if a more substantial copy is required, should be directed in the owner(s) of the Intellectual Property Rights. Susan Manju Joseph ACKNOWLEDGEMENTS I would like to express my immense gratitude to my supervisor Prof. Stephen Forsythe for having offered me the opportunity to work on this very exciting project and for having been a motivating and inspiring mentor as well as friend through every stage of this PhD. His constant encouragement and availability for frequent meetings have played a very key role in the progress of this research project. I would also like to thank my co-supervisors, Dr. Alan McNally and Prof. Graham Ball for all the useful advice, guidance and participation they provided during the course of this PhD study. -
Reverse Blot Hybridization Assay
Detection of Waterborne Pathogens by Polymerase Chain Reaction- Reverse Blot Hybridization Assay Yeonim Choi The Graduate School Yonsei University Department of Biomedical Laboratory Science Detection of Waterborne Pathogens by Polymerase Chain Reaction- Reverse Blot Hybridization Assay A Dissertation Submitted to the Department of Biomedical Laboratory Science and the Graduate School of Yonsei University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Yeonim Choi July 2011 G This certifies that the dissertation of Yeonim Choi is approved. Thesis Supervisor : Hyeyoung Lee Ok Doo Awh : Thesis Committee Member Tae Ue Kim : Thesis Committee Member Jong Bae Kim : Thesis Committee Member Yong Serk Park : Thesis Committee Member The Graduate School Yonsei University July 2011 G G Dedicated to my family and my friends, who have encouraged me. G G CONTENTS LIST OF FIGURES AND TABLES ------------------------------------------------ iv ABBREVIATIONS ------------------------------------------------------------------- ix ABSTRACT IN ENGLISH ----------------------------------------------------------- x I. INTRODUCTION ------------------------------------------------------------- 1 II. MATERIALS AND METHODS -------------------------------------------- 9 1. Development of PCR-REBA targeting waterborne pathogens -------- 9 Bacterial reference strains and cultivation ------------------------------- 9 Genomic DNA extraction -
Taqman® Cronobacter Sakazakii Detection
Applied Biosystems Food Pathogen Detection System TaqMan ® Cronobacter sakazakii Detection Kit Simple, reliable, and rapid detection TaqMan® Pathogen Detection Kits • Cronobacter sakazakii • Salmonella enterica • Campylobacter jejuni • E. coli O157:H7 • Listeria monocytogenes • Pseudomonas aeruginosa • Staphylococcus aureus An Infant Formula Contaminant Real-Time PCR Delivers Detect E. sakazakii Faster Cronobacter sakazakii is a pathogen The TaqMan Cronobacter sakazakii A number of tests are currently mostly associated with powdered Detection Kit uses proven real-time available that identify Cronobacter infant formula, causing seizures, brain PCR technology designed to provide: sakazakii based on phenotypic and abscesses, developmental delay, and biochemical methods. However, • Highly selective identification of even death in infants with premature because of isolates that may escape Cronobacter sakazakii in a wide variety infants and newborns at greatest risk. identification with these methods, faster, of food and finished product samples It is therefore extremely important more reliable methods are needed. that infant formula be tested prior to • Verified performance The TaqMan® Cronobacter sakazakii release to the marketplace. It is currently Detection Kit offers such an alternative. • Ready-to-use convenience unknown how many organisms will cause infection, thus a highly specific • Reduced risk of contamination product testing method is necessary to determine the presence of Cronobacter sakazakii. Rely on Applied Biosystems Use a Complete -
Pocket Guide to Clinical Microbiology
4TH EDITION Pocket Guide to Clinical Microbiology Christopher D. Doern 4TH EDITION POCKET GUIDE TO Clinical Microbiology 4TH EDITION POCKET GUIDE TO Clinical Microbiology Christopher D. Doern, PhD, D(ABMM) Assistant Professor, Pathology Director of Clinical Microbiology Virginia Commonwealth University Health System Medical College of Virginia Campus Washington, DC Copyright © 2018 Amer i can Society for Microbiology. All rights re served. No part of this publi ca tion may be re pro duced or trans mit ted in whole or in part or re used in any form or by any means, elec tronic or me chan i cal, in clud ing pho to copy ing and re cord ing, or by any in for ma tion stor age and re trieval sys tem, with out per mis sion in writ ing from the pub lish er. Disclaimer: To the best of the pub lish er’s knowl edge, this pub li ca tion pro vi des in for ma tion con cern ing the sub ject mat ter cov ered that is ac cu rate as of the date of pub li ca tion. The pub lisher is not pro vid ing le gal, med i cal, or other pro fes sional ser vices. Any ref er ence herein to any spe cific com mer cial prod ucts, pro ce dures, or ser vices by trade name, trade mark, man u fac turer, or oth er wise does not con sti tute or im ply en dorse ment, rec om men da tion, or fa vored sta tus by the Ameri can Society for Microbiology (ASM). -
Antimicrobial Resistance EMERGING INFECTIOUS DISEASES Pages 681-814 Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 681–814
Vol 13, No 5, May 2007 Vol ® May 2007 Antimicrobial Resistance EMERGING INFECTIOUS DISEASES Pages 681-814 Pages Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 681–814 EDITOR-IN-CHIEF D. Peter Drotman EDITORIAL STAFF EDITORIAL BOARD Managing Senior Editor Dennis Alexander, Addlestone Surrey, United Kingdom Polyxeni Potter, Atlanta, Georgia, USA Barry J. Beaty, Ft. Collins, Colorado, USA Associate Editors Martin J. Blaser, New York, New York, USA Paul Arguin, Atlanta, Georgia, USA David Brandling-Bennet, Washington, D.C., USA Charles Ben Beard, Ft. Collins, Colorado, USA Donald S. Burke, Baltimore, Maryland, USA David Bell, Atlanta, Georgia, USA Arturo Casadevall, New York, New York, USA Jay C. Butler, Anchorage, Alaska, USA Kenneth C. Castro, Atlanta, Georgia, USA Charles H. Calisher, Ft. Collins, Colorado, USA Thomas Cleary, Houston, Texas, USA Stephanie James, Bethesda, Maryland, USA Anne DeGroot, Providence, Rhode Island, USA Brian W.J. Mahy, Atlanta, Georgia, USA Vincent Deubel, Shanghai, China Paul V. Effler, Honolulu, Hawaii, USA Nina Marano, Atlanta, Georgia, USA Ed Eitzen, Washington, D.C., USA Martin I. Meltzer, Atlanta, Georgia, USA Duane J. Gubler, Honolulu, Hawaii, USA David Morens, Bethesda, Maryland, USA Richard L. Guerrant, Charlottesville, Virginia, USA J. Glenn Morris, Baltimore, Maryland, USA Scott Halstead, Arlington, Virginia, USA Marguerite Pappaioanou, St. Paul, Minnesota, USA David L. Heymann, Geneva, Switzerland Tanja Popovic, Atlanta, Georgia, USA Daniel B. Jernigan, Atlanta, Georgia, USA Patricia M. Quinlisk, Des Moines, Iowa, USA Charles King, Cleveland, Ohio, USA Jocelyn A. Rankin, Atlanta, Georgia, USA Keith Klugman, Atlanta, Georgia, USA Didier Raoult, Marseilles, France Takeshi Kurata, Tokyo, Japan Pierre Rollin, Atlanta, Georgia, USA S.K. -
Prevalence, Distribution, and Phylogeny of Type Two Toxin-Antitoxin Genes Possessed by Cronobacter Species Where C. Sakazakii Homologs Follow Sequence Type Lineages
microorganisms Article Prevalence, Distribution, and Phylogeny of Type Two Toxin-Antitoxin Genes Possessed by Cronobacter Species where C. sakazakii Homologs Follow Sequence Type Lineages Samantha Finkelstein, Flavia Negrete, Hyein Jang, Jayanthi Gangiredla, Mark Mammel, Isha R. Patel, Hannah R. Chase, JungHa Woo, YouYoung Lee, Caroline Z. Wang, Leah Weinstein, Ben D. Tall * and Gopal R. Gopinath Center of Food Safety and Applied Nutrition, U. S. Food and Drug Administration, 8301 MuirKirk Rd, Laurel, MD 20708, USA; sfi[email protected] (S.F.); [email protected] (F.N.); [email protected] (H.J.); [email protected] (J.G.); [email protected] (M.M.); [email protected] (I.R.P.); [email protected] (H.R.C.); [email protected] (J.W.); [email protected] (Y.L.); [email protected] (C.Z.W.); [email protected] (L.W.); [email protected] (G.R.G.) * Correspondence: [email protected] Received: 4 October 2019; Accepted: 9 November 2019; Published: 12 November 2019 Abstract: Cronobacter species are a group of foodborne pathogenic bacteria that cause both intestinal and systemic human disease in individuals of all age groups. Little is known about the mechanisms that Cronobacter employ to survive and persist in foods and other environments. Toxin–antitoxin (TA) genes are thought to play a role in bacterial stress physiology, as well as in the stabilization of horizontally-acquired re-combinatorial elements such as plasmids, phage, and transposons. TA systems have been implicated in the formation of a persistence phenotype in some bacterial species including Escherichia coli and Salmonella. -
APPENDIX a Media and Reagents
APPENDIX A Media and Reagents Pauline K. w. Yu, M.S. The use of appropriate and dependable media is integral to the isolation and identification of microorganisms. Unfortunately, comparative data docu menting the relative efficacy or value of media designed for similar purposes are often lacking. Moreover, one cannot presume identity in composition of a given generic product which is manufactured by several companies because each may supplement the generic products with components, often of a proprietary nature and not specified in the product's labeling. Finally, the actual production of similar products may vary among manufacturers to a sufficient extent to affect their performance. For all of these reasons, therefore, product selection for the laboratory should not be strictly based on cost considerations and should certainly not be based on promotional materials. Evaluations that have been published in the scientific literature should be consulted when available. Alternatively, the prospective buyer should consult a recognized authority in the field. It is seldom necessary for the laboratory to prepare media using basic components since these are usually available combined in dehydrated form from commercial sources; however, knowledge of a medium's basic compo nents is helpful in understanding how the medium works and what might be wrong when it does not work. Hence, the components have been listed for each medium included in this chapter. All dehydrated media must be prepared exactly according to the manu facturers' directions. Any deviation from these directions may adversely affect or significantly alter a medium's performance. Containers of media should be dated on receipt and when opened, and the media should never be used beyond expiration dates specified by the manufacturers or recom mended by quality control programs. -
Infant and New Mother
Infant and New Mother Product Category: Infant and New Mother EleCare® Similac Expert Care® 24 Cal With Iron EleCare® (for Infants) Similac Expert Care® Alimentum® Similac Expert Care® for Diarrhea Similac Expert Care® NeoSure® Metabolic Similac For Spit-Up® Calcilo XD® Similac Go & Grow® Milk-Based Formula Cyclinex®-1 Similac Go & Grow® Soy-Based Formula Glutarex®-1 Similac Sensitive® Hominex®-1 Similac Total Comfort™ I-Valex®-1 Similac® 10-pct Glucose Water Ketonex®-1 Similac® 5-pct Glucose Water Phenex™-1 Similac® Advance® Pro-Phree® Similac® Advance® Organic Propimex®-1 Similac® For Supplementation ProViMin® Similac® Human Milk Fortifier RCF® Similac® Human Milk Fortifier Concentrated Liquid Tyrex®-1 Similac® Nipples Similac® PM 60/40 Pedialyte® Similac® Prenatal & Breastfeeding Dietary Supplement Pedialyte AdvancedCare™ Pedialyte® Liters Similac® Simply Smart™ Similac® Soy Isomil® Similac® Similac® Sterilized Water Similac® Volu-Feed® Bottles & Caps Liquid Protein Fortifier For more information, contact your Abbott Nutrition Representative or visit www.abbottnutrition.com Abbott Nutrition Abbott Laboratories © 2013 Abbott Laboratories Inc. Columbus, OH 43219-3034 Updated 11/18/2013 1-800-227-5767 EleCare® Product Category: EleCare® EleCare® (for Infants) For more information, contact your Abbott Nutrition Representative or visit www.abbottnutrition.com Abbott Nutrition Abbott Laboratories © 2013 Abbott Laboratories Inc. Columbus, OH 43219-3034 Updated 11/18/2013 1-800-227-5767 EleCare® (for Infants) Nutritionally Complete Amino Acid-Based Infant Formula with Iron Product Information: EleCare® (for Infants) For more information, contact your Abbott Nutrition Representative or visit www.abbottnutrition.com Abbott Nutrition Abbott Laboratories © 2013 Abbott Laboratories Inc. Columbus, OH 43219-3034 Updated 1/1/0001 1-800-227-5767 1 of 5 EleCare® (for Infants) Nutritionally Complete Amino Acid-Based Infant Formula with Iron l EleCare is a nutritionally complete amino-acid based formula for infants who cannot tolerate intact or hydrolyzed protein. -
Biocontrol of Cronobacter Spp. Using Bacteriophage in Infant Formula
i Biocontrol of Cronobacter spp. using Bacteriophage in Infant Formula by Reza Abbasifar A Thesis presented to The University of Guelph In partial fulfillment of requirements for the degree of Doctor of Philosophy in Food Science Guelph, Ontario, Canada © Reza Abbasifar, May, 2013 ii ABSTRACT Biocontrol of Cronobacter spp. using Bacteriophage in Infant Formula Reza Abbasifar Advisor: Dr. Mansel W. Griffiths University of Guelph, 2013 Co-Advisor: Dr. Parviz M. Sabour The purpose of this research was to explore the potential application of lytic phages to control Cronobacter spp. in infant formula. More than two hundred and fifty phages were isolated from various environmental samples against different strains of Cronobacter spp. Selected phages were characterized by morphology, host range, and cross infectivity. The genomes of five novel Cronobacter phages [vB_CsaM_GAP31 (GAP31), vB_CsaM_GAP32 (GAP32), vB_CsaP_GAP52 (GAP52), vB_CsaM_GAP161 (GAP161), vB_CsaP_GAP227 (GAP227)] were sequenced. Phage GAP32 possess the second largest phage genome sequenced to date, and it is proposed that GAP32 belongs to a new genus of “Gap32likeviruses”. Phages GAP52 and GAP227 are the first C. sakazakii podoviruses whose genomes have been sequenced. None of the sequenced genomes showed homology to virulent or lysogenic genes. In addition, in vivo administration of phage GAP161 in the hemolymph of Galleria mellonella larvae showed no negative effects on the wellbeing of the larvae and could effectively prevent Cronobacter infection in the larvae. A cocktail of five phages was highly effective for biocontrol of three Cronobacter sakazakii strains present as a mixed culture in both broth media and contaminated reconstituted infant formula. This phage cocktail could be iii potentially used to control C. -
International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485
International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’. -
BD Industry Catalog
PRODUCT CATALOG INDUSTRIAL MICROBIOLOGY BD Diagnostics Diagnostic Systems Table of Contents Table of Contents 1. Dehydrated Culture Media and Ingredients 5. Stains & Reagents 1.1 Dehydrated Culture Media and Ingredients .................................................................3 5.1 Gram Stains (Kits) ......................................................................................................75 1.1.1 Dehydrated Culture Media ......................................................................................... 3 5.2 Stains and Indicators ..................................................................................................75 5 1.1.2 Additives ...................................................................................................................31 5.3. Reagents and Enzymes ..............................................................................................75 1.2 Media and Ingredients ...............................................................................................34 1 6. Identification and Quality Control Products 1.2.1 Enrichments and Enzymes .........................................................................................34 6.1 BBL™ Crystal™ Identification Systems ..........................................................................79 1.2.2 Meat Peptones and Media ........................................................................................35 6.2 BBL™ Dryslide™ ..........................................................................................................80